Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Most Competitive Residency Programs in US

In this article, we will discuss the 15 most competitive residency programs in the United States. You can skip our detailed analysis and directly proceed to the 5 Most Competitive Residency Programs in the US.

A multitude of medical school graduates compete for a limited number of coveted spots each year, within the prestigious residency programs of the United States. The competition is nothing short of intense, evidenced by the exponential surge in applications, the elevated level of difficulty, and the strikingly low acceptance rates.

According to data released by the National Residency Matching Program (NRMP) on June 1st 2022, there exist certain residency programs that stand out due to their stringent training regimens and stellar reputation. These programs have garnered a notorious reputation for their complexity when it comes to gaining admission.

For fresh medical school graduates, these residency programs hold the promise of providing invaluable firsthand clinical experience, paving the way for a promising and luminous future in their respective medical specialties. Those fortunate enough to secure a position within these programs invariably represent the pinnacle of the medical industry, possessing exceptional qualities of resilience, unwavering dedication, and advanced clinical expertise.

The Growth and Impact of Residency Programs in the United States

Stats from NRMP released on June 1, 2022, show that the Main Residency Match in 2022 witnessed a total of 47,675 registrants, which was 1,025 fewer than the preceding year, marking the first decline in registrant numbers since 2003. Among these participants, there were 42,549 active applicants.

According to a Accreditation Council for Graduate Medical Education (ACGME) release, published on October 10, 2022, the academic year 2021-2022 witnessed a total of 12,740 accredited programs. Among these, 5,579 were categorized as specialty programs, while 7,161 fell under the subspecialty category. Moreover, 384 programs obtained accreditation status during this academic year. On the other hand, 42 programs either closed or voluntarily withdrew their accreditation, with 14 of them experiencing actions such as Accreditation Withdrawn or Administrative Withdrawal.

In terms of residents and fellows, there were 153,843 individuals actively enrolled in the 12,740 programs. This represented an increase of 4,643 compared to the previous year. Among these 153,843 active residents and fellows in ACGME-accredited programs during the Academic Year 2021-2022, the majority, accounting for 59.6%, hailed from Liaison Committee on Medical Education-accredited medical schools in the United States. International medical school graduates constituted 22.9% of the total, while 17.4% were graduates of osteopathic medical schools.

Competitive residency programs in the US also offer unbeatable opportunities for networking and career development. Due to the extensive range of collaborations they entail, trainees have the advantage of forging professional relationships with mentors, peers, and leading experts in research and practice.

An additional key element driving competition is the ever-growing demand for qualified medical professionals in the United States. As the population continues to increase and age, there is an insatiable need for more physicians, resulting in an amplified supply-demand disparity.

A report by Association of American Medical Colleges (AAMC), published on June 11, 2021, predicted a physician shortage in the United States, ranging from 37,800 to 124,000 by 2034. Such projections amplify the ambition of medical students, as they strive to secure coveted spots in competitive residency programs, highlighting the growing importance of securing a position on the path to becoming a physician.

Physicians can work with some of the top healthcare facilities and services providers including HCA Healthcare (NYSE:HCA), Pediatrix Medical Group (NYSE:MD), and Amedisys (NASDAQ:AMED). Let’s discuss some business updates regarding these organizations.

On August 3, Pediatrix Medical Group (NYSE:MD) reported earnings for the fiscal second quarter of 2023. The company reported earnings per share of $0.39 and generated a revenue of $500.58 million for the quarter, up 2.99% year over year and ahead of Wall Street estimates by $4.73 million.

On September 27, Boston Globe reported that HCA Healthcare (NYSE:HCA) entered a preliminary phase for a possible union with the Catholic Medical Center (CMC) through an exploratory non-binding letter of intent. This action will be followed by further due diligence, negotiations of the final terms, and procuring the required consents. The merger will further the cause of both HCA Healthcare (NYSE:HCA) and CMC in the region.

As reported by Reuters on June 5, UnitedHealth Group Inc. (NYSE:UNH) has made an offer to buy Amedisys (NASDAQ:AMED). UnitedHealth Group Inc. (NYSE:UNH), through its Optum unit, offered a $3.26 billion all-cash bid to acquire home health and hospice care firm Amedisys (NASDAQ:AMED), placing itself in direct competition with Option Care Health, Inc. (NASDAQ:OPCH), which had previously agreed to buy Amedisys (NASDAQ:AMED) for $97.38 per share in an all-stock transaction. This move comes amid a surge in interest for the home health sector since the pandemic, as patients and caregivers increasingly prefer at-home medical services, prioritizing safety.

Students who pass through competitive residency programs can eventually work in the best hospitals in the United States. For greater insights regarding the same, view our article on the 25 Best Hospitals in the U.S.

Understanding PGY-1 and PGY-2 Positions

Residency programs in the United States typically follow a “PGY” system or “Post-Graduate Year.” These numbers, PGY-1, PGY-2, and so forth, indicate the progression of a resident’s training within their chosen medical specialty.

The PGY-1 year, also known as the “internship” or “first-year residency,” is the first year of a doctor’s specialized training after graduating from medical school. During that year, residents receive  broad clinical experience in various medical disciplines, including internal medicine, pediatrics, general surgery, emergency medicine, and others pertinent to their chosen specialty.

PGY-1 residents, under the supervision of higher-level residents and attending physicians, begin to take on clinical responsibilities. They examine patients, make diagnoses, develop and execute treatment plans, perform basic medical procedures, and engage in direct patient care.

PGY-2, or the “second-year residency,” takes the foundational clinical skills gained during the PGY-1 year and advances them further. The PGY-2 year often involves increased clinical responsibility, more advanced procedures, and in-depth exploration of the resident’s chosen specialty.

Some programs have their first official year labeled as “PGY-2”, which is common in specialties that require a preliminary clinical year in another field, such as internal medicine. Physicians at this stage are termed PGY-2 residents, regardless of whether it is their second official year of residency. For example, in radiation oncology and dermatology, the official residency program starts at the PGY-2 level.

Our list of the most competitive residency programs in the US will discuss PGY-1 and PGY-2 openings across residency programs in the United States.

uzhursky/Shutterstock.com

Methodology

To identify the most competitive residency programs in the United States, we utilized data from the National Residency Matching Program and their corresponding list of Average USMLE Step 2 CK scores accepted by the different programs.

We conducted an additional assessment to check the number of applicants for the program and the number of corresponding PGY-1 and PGY-2 positions. Some residencies offer both PGY-1 and PGY-2 positions for a specific Match year, while others just offer either PGY-1 or PGY-2 positions. The data, when connected with the most recent average USMLE Step 2 CK scores released in July 2022, helped us compile the list in ascending order. The higher the average USMLE Step 2 CK Score for a residency program, the more difficult it becomes for aspiring doctors to get into.

Having covered these particulars, let us now proceed to rank the most competitive residency programs in the United States.

Note: These stats are for 2022, and while competitiveness remains the same, average scores can vary from year to year.

15 Most Competitive Residency Programs in the United States

15. Family Medicine

Number of PGY-1 positions: 5,088

Number of applicants: 6,927

Average USMLE Step 2 CK score: 241

Family medicine residents gain experience in a wide range of medical disciplines, from pediatrics to geriatrics. Due to its broad scope, this residency program offers excellent applicability in both urban and rural settings, where primary care physicians are in high demand. Graduates from family medicine residency programs have a high success rate in obtaining positions in hospitals, clinics, and private practices.

Some of the top companies active in the health care facilities market include HCA Healthcare (NYSE:HCA), Pediatrix Medical Group (NYSE:MD), and Amedisys (NASDAQ:AMED).

14. Psychiatry

Number of PGY-1 positions: 2,164

Number of applicants: 3,039

Average USMLE Step 2 CK score: 242

Psychiatry residency programs offer specialized training in diagnosing and treating mental health illnesses in patients of all ages. Students in these programs gain hands-on experience with the latest methodologies and technologies used in the field, including various psychotherapies and pharmacological interventions. A psychiatry residency program can lead to a wide range of exciting and rewarding career opportunities in psychology and medicine.

13. Pediatrics

Number of PGY-1 positions: 2,986

Number of applicants: 3,724

Average USMLE Step 2 CK score: 245

Pediatrics residency programs focus on providing comprehensive medical care for infants, children, and adolescents, encompassing preventive care, diagnosing and treating illnesses, and educating families on child health and development. Pediatric residency graduates are equipped with the skills and knowledge necessary to care for young patients.

12. Pathology

Number of PGY-1 positions: 613

Number of applicants: 1023

Average USMLE Step 2 CK score: 245

The Pathology residency program has an average score of 245, and 1,023 applicants vie for 613 PGY-1 spots. This program offers in-depth training in diagnosing diseases and understanding pathological processes through laboratory analyses, such as tissue and cell examination.

11. Emergency Medicine

Number of PGY-1 positions: 3,010

Number of applicants: 2,765

Average USMLE Step 2 CK score: 247

Emergency Medicine provides rigorous training in a wide range of scenarios encountered in the emergency department. Due to the ever-present need for emergency medicine practitioners, the applicability of this residency program is immense and graduates find opportunities in various healthcare settings. The program focuses on acute care, equipping residents with the skills to diagnose, stabilize, and manage patients with life-threatening emergencies and time-sensitive illnesses.

10. Radiation Oncology

Number of PGY-1 positions: 10

Number of PGY-2 positions: 181

Number of applicants: 108

Average USMLE Step 2 CK score: 249

Radiation Oncology, with an average score of 249, is highly competitive due to its limited positions (181 total) for 108 applicants, and ranks 10th on our list of most competitive residency programs in the US. This residency program trains physicians to deliver targeted radiation therapy to treat malignant and benign conditions, including cancer.

9. Internal Medicine – Pediatrics

Number of PGY-1 positions: 392

Number of applicants: 571

Average USMLE Step 2 CK score: 250

Internal Medicine focuses on the comprehensive care of adult patients. With a strong emphasis on clinical reasoning and evidence-based practice, internal medicine residents develop the skills necessary to diagnose and manage a wide array of medical conditions. Applicability of this residency program is wide-ranging, allowing graduates to pursue various career paths, including primary care, hospital medicine, or subspecialties.

8. Vascular Surgery

Number of PGY-1 positions: 93

Number of PGY-2 positions: None

Number of applicants: 159

Average USMLE Step 2 CK score: 250

Vascular Surgery has a 250 average score, with 159 applicants vying for 93 PGY-1 positions, and is among the most competitive medical residencies. This surgical residency program provides specialized training in diagnosing and managing peripheral vascular diseases through various surgical, endovascular, and medical treatments.

7. Neurosurgery

Number of PGY-1 positions: 243

Number of PGY-2 positions: None

Number of applicants: 373

Average USMLE Step 2 CK score: 252

The neurosurgery program offers comprehensive training and mentorship, equipping aspiring neurosurgeons with the necessary skills and knowledge required for handling matters of the brain. This rigorous surgical residency program trains physicians in complex surgical procedures focusing on the brain, spine, and peripheral nerves.

6. Interventional Radiology

Number of PGY-1 positions: 51

Number of PGY-2 positions: 125

Number of applicants: 266

Average USMLE Step 2 CK score: 253

Interventional Radiology boasts an impressive average score of 253 and attracts 266 applicants vying for just 176 available positions, establishing itself as one of the premier residency programs in its specialty. This program provides comprehensive training in cutting-edge, image-guided diagnostic and therapeutic procedures for a wide spectrum of medical conditions.

HCA Healthcare (NYSE:HCA), Pediatrix Medical Group (NYSE:MD), and Amedisys (NASDAQ:AMED) are renowned for their ability to recruit and retain top-tier medical professionals nationwide.

Click to continue reading and see the 5 Most Competitive Residency Programs in the US.

Suggested Articles:

Disclosure: none. 15 Most Competitive Residency Programs in the US is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…